Compound guides and the reconstitution calculator.
Nerve repair & metabolic recovery
Vial 10 mg · 1 mL water
Immune optimisation
Vial 10 mg · 2 mL water
Systemic energy & cell repair
Vial 1,000 mg · 5 mL water
Cognitive enhancement & neurogenesis
Vial 10,000 mcg · 3 mL water
Mitochondrial rejuvenation
Vial 50 mg · 1 mL water
Testicular function & fertility support
Vial 5,000 IU · 2 mL water
Investigational triple-agonist (GLP-1 / GIP / glucagon)
Drafted from public sourcesVial 20 mg · 2 mL water
Approved GLP-1 / GIP weekly injection (Zepbound, Mounjaro)
Drafted from public sourcesVial 60 mg · 2.4 mL water
GHK-Cu + BPC-157 + TB-500 + KPV premix (supplier-dependent)
Drafted from public sourcesVial 80 mg · 3 mL water
Prescription growth hormone; label adult dosing vs community IU use
Drafted from public sourcesVial 15 IU · 1.5 mL water
Mitochondrial-derived peptide (preclinical and early-trial evidence)
Drafted from public sourcesVial 10 mg · 0.5 mL water
Investigational long-acting amylin receptor agonist (Lilly, LY3841136)
Drafted from public sourcesVial 10 mg · 0.5 mL water
Tuftsin-derived heptapeptide; registered in Russia as a nasal anxiolytic
Drafted from public sourcesVial 5,000 mcg · 2 mL water
Khavinson cartilage bioregulator tripeptide (Ala-Glu-Asp)
Drafted from public sourcesVial 20 mg · 0.4 mL water
Preclinical NNMT inhibitor (small molecule)
Drafted from public sourcesVial 100 mg · 1 mL water
FDA-approved melanocortin receptor agonist (Vyleesi) for low sexual desire in premenopausal women
Drafted from public sourcesVial 10 mg · 1 mL water
Approved obstetric injectable (IV/IM); intranasal use for social cognition is off-label research
Drafted from public sourcesVial 100 IU · 1 mL water
Unapproved research peptide popular for tendon, joint and gut recovery; human evidence is a handful of tiny uncontrolled reports
Drafted from public sourcesVial 5,000 mcg · 2 mL water
A seven-residue thymosin beta-4 fragment sold for recovery; not the full protein, and no human trials of the fragment found
Drafted from public sourcesVial 5 mg · 1 mL water
Copper peptide with solid-looking topical skin data; injected use has no human studies
Drafted from public sourcesVial 10 mg · 2 mL water
Lys-Pro-Val tripeptide from alpha-MSH; anti-inflammatory in mouse colitis, never tested in humans
Drafted from public sourcesVial 5,000 mcg · 2.5 mL water
Human cathelicidin antimicrobial peptide; tested only as a topical for leg ulcers, where it did not beat placebo overall
Drafted from public sourcesVial 1,000 mcg · 2 mL water
Long-acting growth-hormone-releasing hormone (GHRH) analog; unapproved. Two very different forms: no DAC (Mod GRF 1-29) and with DAC
Drafted from public sourcesVial 2,000 mcg · 2 mL water
Selective ghrelin-receptor GH secretagogue; unapproved. Only human trial was a failed phase 2 for postoperative ileus
Drafted from public sourcesVial 2,000 mcg · 2 mL water
FDA-approved GHRH analog (Egrifta) to reduce excess abdominal fat in adults with HIV-associated lipodystrophy
Drafted from public sourcesVial 2 mg · 0.5 mL water
GHRH 1-29 fragment; formerly FDA-approved (Geref) for GH-deficient children, now compounded
Drafted from public sourcesVial 5,000 mcg · 2.5 mL water
Approved GLP-1 weekly injection (Ozempic, Wegovy)
Drafted from public sourcesVial 5 mg · 2 mL water
Long-acting amylin analogue, investigational (studied with semaglutide as CagriSema)
Drafted from public sourcesVial 5 mg · 2 mL water
Ala-Glu-Asp-Gly tetrapeptide from the Khavinson group; community longevity use
Drafted from public sourcesVial 10 mg · 1 mL water
ACTH(4-7)-derived heptapeptide; registered in Russia as a nasal nootropic
Drafted from public sourcesVial 5,000 mcg · 2 mL water